Brian J. Caveney - Feb 11, 2025 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
EVP, Pres of ED, CMO & CSO
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Brian J. Caveney
Stock symbol
LH
Transactions as of
Feb 11, 2025
Transactions value $
-$33,339
Form type
4
Date filed
2/13/2025, 11:34 AM
Previous filing
Feb 10, 2025
Next filing
Mar 31, 2025
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Award $0 +6.7K $0.00 6.7K Feb 11, 2025 Common Stock 6.7K $245.14 Direct F3, F4
transaction LH Restricted Stock Unit Award $0 +2.22K +90.95% $0.00 4.66K Feb 11, 2025 Common Stock 2.22K Direct F1, F5, F6
transaction LH Restricted Stock Unit Options Exercise $0 -473 -10.15% $0.00 4.19K Feb 11, 2025 Common Stock 473 Direct F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
F4 The option vests in three equal annual installments beginning on the date reflected in this column.
F5 The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
F6 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F7 The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.